1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	only	only	_	_	_	_	_	_	_
3	partially	partially	_	_	_	_	_	_	_
4	mediates	mediate	_	_	_	_	_	_	_
5	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
6	virus	virus	_	_	_	_	_	_	_
7	latent	latent	_	_	_	_	_	_	_
8	membrane	membrane	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	1	1	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	latent	latent	_	_	_	_	_	_	_
3	membrane	membrane	_	_	_	_	_	_	_
4	protein	protein	_	_	_	_	_	_	_
5	1	1	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	LMP1	lmp1	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
11	virus	virus	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	EBV	EBV	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	required	require	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	EBV-induced	ebv-induced	_	_	_	_	_	_	_
19	immortalization	immortalization	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	B	B	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	causes	cause	_	_	_	_	_	_	_
26	tumorigenic	tumorigenic	_	_	_	_	_	_	_
27	transformation	transformation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	cell	cell	_	_	_	_	_	_	_
30	lines	line	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	LMP1	lmp1	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	induces	induce	_	_	_	_	_	_	_
4	phenotypic	phenotypic	_	_	_	_	_	_	_
5	changes	change	_	_	_	_	_	_	_
6	resembling	resemble	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	such	such	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	size	size	_	_	_	_	_	_	_
15	increase	increase	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	up-regulation	up-regulation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	surface	surface	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	markers	marker	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	LMP1	LMP1	_	_	_	_	_	_	_
2	contains	contain	_	_	_	_	_	_	_
3	two	two	_	_	_	_	_	_	_
4	domains	domain	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	activate	activate	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	one	one	_	_	_	_	_	_	_
13	through	through	_	_	_	_	_	_	_
14	interactions	interaction	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	TRAF	TRAF	_	_	_	_	_	_	_
17	proteins	protein	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	other	other	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	TRADD	TRADD	_	_	_	_	_	_	_
24	protein	protein	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	purpose	purpose	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	present	present	_	_	_	_	_	_	_
6	study	study	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	investigate	investigate	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	importance	importance	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	induction	induction	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	up-regulation	up-regulation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	activation	activation	_	_	_	_	_	_	_
23	markers	marker	_	_	_	_	_	_	_
24	ICAM-1	icam-1	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	CD71	CD71	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	LMP1	LMP1	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	shows	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	LMP1	LMP1	_	_	_	_	_	_	_
8	activates	activate	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	p50/p65-	p50/p65-	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	c-Rel-	c-rel-	_	_	_	_	_	_	_
14	responsive	responsive	_	_	_	_	_	_	_
15	promoters	promoter	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	this	this	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	can	can	_	_	_	_	_	_	_
22	be	be	_	_	_	_	_	_	_
23	completely	completely	_	_	_	_	_	_	_
24	inhibited	inhibit	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	expression	expression	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	dominant	dominant	_	_	_	_	_	_	_
30	inhibitory	inhibitory	_	_	_	_	_	_	_
31	IkappaB	ikappab	_	_	_	_	_	_	_
32	mutant	mutant	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	ICAM-1	ICAM-1	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	CD71	CD71	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	nevertheless	nevertheless	_	_	_	_	_	_	_
6	up-regulated	up-regulate	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	LMP1	lmp1	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	primary	primary	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	lines	line	_	_	_	_	_	_	_
16	expressing	express	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	dominant	dominant	_	_	_	_	_	_	_
19	IkappaB	ikappab	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	LMP1-induced	lmp1-induced	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	size	size	_	_	_	_	_	_	_
6	increase	increase	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	primary	primary	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	unaffected	unaffected	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	IkappaB	IkappaB	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	concluded	conclude	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	even	even	_	_	_	_	_	_	_
6	when	when	_	_	_	_	_	_	_
7	LMP1	lmp1	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	unable	unable	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	activate	activate	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	it	it	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	still	still	_	_	_	_	_	_	_
17	capable	capable	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	inducing	induce	_	_	_	_	_	_	_
20	certain	certain	_	_	_	_	_	_	_
21	characteristics	characteristic	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	activated	activate	_	_	_	_	_	_	_
24	B	b	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	strongly	strongly	_	_	_	_	_	_	_
28	suggesting	suggest	_	_	_	_	_	_	_
29	that	that	_	_	_	_	_	_	_
30	LMP1	lmp1	_	_	_	_	_	_	_
31	can	can	_	_	_	_	_	_	_
32	also	also	_	_	_	_	_	_	_
33	activate	activate	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	independently	independently	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

